|
1
|
Cacoub P, Comarmond C, Domont F, Savey L
and Saadoun D: Cryoglobulinemia Vasculitis. Am J Med. 128:950–955.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gragnani L, Fognani E, Piluso A, Boldrini
B, Urraro T, Fabbrizzi A, Stasi C, Ranieri J, Monti M, Arena U, et
al: MaSVE Study Group: Long-term effect of HCV eradication in
patients with mixed cryoglobulinemia: A prospective, controlled,
open-label, cohort study. Hepatology. 61:1145–1153. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alpers CE and Smith KD: Cryoglobulinemia
and renal disease. Curr Opin Nephrol Hypertens. 17:243–249. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mishra J, Dent C, Tarabishi R, Mitsnefes
MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, et al:
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker
for acute renal injury after cardiac surgery. Lancet.
365:1231–1238. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weimer LE, Vinci M, Borgia G, Brunetto M,
Sturace L, Gaeta GB, Chemello L, Buggio A, Andreone P and Raimondo
G: HCV-related mixed cryoglobulinemia: Data from PITER, a
nationwide Italian HCV cohort study. Digestive and Liver Disease.
48:e6–e7. 2016. View Article : Google Scholar
|
|
6
|
Eltayeb S, Berg AL, Lassmann H, Wallström
E, Nilsson M, Olsson T, Ericsson-Dahlstrand A and Sunnemark D:
Temporal expression and cellular origin of CC chemokine receptors
CCR1, CCR2 and CCR5 in the central nervous system: insight into
mechanisms of MOG-induced EAE. J Neuroinflammation. 4:1–13. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stutz A, Kolbe CC, Stahl R, Horvath GL,
Franklin BS, van Ray O, Brinkschulte R, Geyer M, Meissner F and
Latz E: NLRP3 inflammasome assembly is regulated by phosphorylation
of the pyrin domain. J Exp Med. 214:1725–1736. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosengren S, Hoffman HM, Bugbee W and
Boyle DL: Expression and regulation of cryopyrin and related
proteins in rheumatoid arthritis synovium. Ann Rheum Dis.
64:708–714. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong JI, You SL and Xin SJ: Interpretation
of the Chinese guideline of prevention and treatment for hepatitis
C (2015 updated version). Infectious Disease Information. 1:20–23.
2016.
|
|
10
|
Saadoun D, Pol S, Ferfar Y, Alric L,
Hezode C, Ahmed Si SN, de Saint Martin L, Comarmond C, Bouyer AS,
Musset L, et al: Efficacy and safety of sofosbuvir plus daclatasvir
for treatment of HCV-associated cryoglobulinemia vasculitis.
Gastroenterology. 153(49–52): e52017.
|
|
11
|
Palombo SB, Wendel EC, Kidd LR, Yazdi F
and Naljayan MV: Clinical Nephrology: MPGN and mixed
cryoglobulinemia in a patient with hepatitis C - new treatment
implications and renal outcomes. Clin Nephrol Case Stud. 5:66–69.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang L, Marcell L and Kottilil S: Systemic
manifestations of hepatitis C infection. Infect Agent Cancer.
11:292016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okazaki M, Yaomura T, Tsuboi T, Mizuno S,
Nakamura T, Hasegawa T, Katayama M, Nakamura H, Iida H, Saito T, et
al: A case of acute renal failure of multiple myeloma due to
monoclonal type I cryoglobulinemia with thrombotic microangiopathy.
CEN Case Rep. 4:174–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Quartuccio L, Zuliani F, Corazza L, Scaini
P, Zani R, Lenzi M, Tavoni A, Sebastiani M, Baldovino S, Urraro T,
et al: Retreatment regimen of rituximab monotherapy given at the
relapse of severe HCV-related cryoglobulinemic vasculitis:
Long-term follow up data of a randomized controlled multicentre
study. J Autoimmun. 63:88–93. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Basile U, Gulli F, Gragnani L, Fognani E,
Napodano C, Pocino K, Zignego AL and Rapaccini GL: IgG3 subclass: A
possible trigger of mixed cryoglobulin cascade in hepatitis C virus
chronic infection. Dig Liver Dis. 49:1233–1239. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murooka TT, Wong MM, Rahbar R,
Majchrzak-Kita B, Proudfoot AE and Fish EN: CCL5-CCR5-mediated
apoptosis in T cells: Requirement for glycosaminoglycan binding and
CCL5 aggregation. J Biol Chem. 281:25184–25194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carpenter D, Taype C, Goulding J, Levin M,
Eley B, Anderson S, Shaw MA and Armour JA: CCL3L1 copy number, CCR5
genotype and susceptibility to tuberculosis. BMC Med Genet.
15:52014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dobaczewski M, Xia Y, Bujak M,
Gonzalez-Quesada C and Frangogiannis NG: CCR5 signaling suppresses
inflammation and reduces adverse remodeling of the infarcted heart,
mediating recruitment of regulatory T cells. Am J Pathol.
176:2177–2187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aguilar F, Núñez-Roldán A, Torres B,
Wichmann I, Sánchez-Román J and González-Escribano MF: Chemokine
receptor CCR2/CCR5 polymorphism in Spanish patients with systemic
lupus erythematosus. J Rheumatol. 30:1770–1774. 2003.PubMed/NCBI
|
|
20
|
Tebas P, Stein D, Tang WW, Frank I, Wang
SQ, Lee G, Spratt SK, Surosky RT, Giedlin MA, Nichol G, et al: Gene
editing of CCR5 in autologous CD4 T cells of persons infected with
HIV. N Engl J Med. 370:901–910. 2014. View Article : Google Scholar : PubMed/NCBI
|
